Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 01-2004 | 10-2003 | 07-2003 | 04-2003 | 01-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 410 | 345 | N/A | -1,177 | -631 |
| Depreciation Amortization | 31 | 16 | N/A | 142 | 96 |
| Accounts receivable | 60 | 650 | N/A | 267 | -730 |
| Other Working Capital | -416 | 594 | N/A | 21 | -682 |
| Other Operating Activity | -181 | -685 | 0 | -825 | 132 |
| Operating Cash Flow | $-97 | $919 | $N/A | $-1,572 | $-1,816 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 1,322 | 1,036 |
| PPE Investments | N/A | N/A | N/A | -17 | -14 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -50 | -50 |
| Other Investing Activity | 163 | 76 | 0 | -50 | 150 |
| Investing Cash Flow | $163 | $76 | $N/A | $1,256 | $1,173 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 27 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $27 | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 1,504 | 1,504 | N/A | 750 | 750 |
| End Cash Position | 1,597 | 2,500 | N/A | 434 | 107 |
| Net Cash Flow | $93 | $995 | $N/A | $-316 | $-643 |
| Free Cash Flow | |||||
| Operating Cash Flow | -97 | 919 | N/A | -1,572 | -1,816 |
| Capital Expenditure | N/A | N/A | N/A | -17 | -14 |
| Free Cash Flow | -97 | 919 | 0 | -1,588 | -1,829 |